Division of Hematology & Oncology

Medicine & Life Sciences

1. 4-ethoxymethylene-2-phenyl-2-oxazoline-5-one 52%
2. Acute Myeloid Leukemia 30%
3. Allogeneic Cells 17%
4. Apoptosis 16%
5. Aspergillus fumigatus 13%
6. Astrocytoma 11%
7. B-Lymphocytes 18%
8. Blood Platelets 40%
9. Bone Marrow 34%
10. Brain 13%
11. Brain Neoplasms 31%
12. Cancer Survivors 22%
13. Carcinogenesis 14%
14. Cell Line 12%
15. Cell Transplantation 48%
16. Central Nervous System 11%
17. Child 61%
18. Chronic Granulomatous Disease 100%
19. Clinical Trials 11%
20. Communication 18%
21. cytochrome b558 35%
22. Cytochromes b 15%
23. DNA Damage 10%
24. Drug Therapy 21%
25. Dyskeratosis Congenita 12%
26. Endoderm 11%
27. Factor VIII 11%
28. Fetal Blood 11%
29. GATA4 Transcription Factor 37%
30. Gene Expression 12%
31. Genes 49%
32. Genetic Therapy 14%
33. Glioblastoma 25%
34. Glioma 28%
35. Graft vs Host Disease 28%
36. Granulocyte Colony-Stimulating Factor 12%
37. Growth 18%
38. Hedgehog Proteins 13%
39. Hematopoiesis 17%
40. Hematopoietic Stem Cell Transplantation 25%
41. Hematopoietic Stem Cells 50%
42. Hemophilia A 21%
43. Hemophilia B 13%
44. Hemorrhage 20%
45. Incidence 10%
46. Infections 15%
47. Inflammation 11%
48. Leukemia 31%
49. Leukocytes 10%
50. Lung 14%
51. Macrophages 14%
52. Medulloblastoma 31%
53. Membranes 12%
54. Mutation 55%
55. Myelodysplastic Syndromes 13%
56. Myeloid Cells 14%
57. NADP 20%
58. NADPH Oxidases 79%
59. Neoplasms 63%
60. Neurofibromatosis 1 28%
61. Neurofibrosarcoma 12%
62. neutrophil cytosol factor 40K 16%
63. neutrophil cytosol factor 67K 15%
64. Neutrophils 55%
65. Optic Nerve Glioma 10%
66. Oxidoreductases 39%
67. Oxygen 12%
68. Parents 18%
69. Pediatrics 82%
70. Peripheral Blood Stem Cells 11%
71. Phagocytes 44%
72. Phenotype 19%
73. Population 12%
74. Precursor Cell Lymphoblastic Leukemia-Lymphoma 13%
75. Proteins 23%
76. Quality of Life 10%
77. Reactive Oxygen Species 14%
78. Recurrence 14%
79. Respiratory Burst 14%
80. Safety 10%
81. Sex Characteristics 13%
82. Sickle Cell Anemia 68%
83. Stem Cell Transplantation 14%
84. Stem Cells 24%
85. superoxide-forming enzyme 13%
86. Superoxides 35%
87. Survival 25%
88. Survivors 20%
89. T-Lymphocytes 13%
90. Therapeutics 29%
91. Thrombosis 17%
92. Tissue Donors 26%
93. Transcription Factors 13%
94. Transplantation 31%
95. Transplants 45%
96. Unrelated Donors 26%
97. von Willebrand Diseases 26%
98. von Willebrand Factor 31%
99. Wilms Tumor 11%
100. Young Adult 20%